Umar Iqbal, MD (@umarp53) header
Umar Iqbal, MD (@umarp53) profile picture

Chief Heme/Onc fellow @Moffittnews, forever 🐊 via @ufimres| love all things myeloid | this account is an observation post for me and my cat.

Joined May 2021
Photo by Umar Iqbal, MD (@umarp53)Photo by Umar Iqbal, MD (@umarp53)Photo by Umar Iqbal, MD (@umarp53)Photo by Umar Iqbal, MD (@umarp53)Photo by Umar Iqbal, MD (@umarp53)Photo by Umar Iqbal, MD (@umarp53)Photo by Umar Iqbal, MD (@umarp53)Photo by Umar Iqbal, MD (@umarp53)Photo by Umar Iqbal, MD (@umarp53)Photo by Umar Iqbal, MD (@umarp53)
🚨 A new cancer vaccine appears to significantly improve survival in people in remission from acute myeloid leukemia (AML), according to new results from a phase 3 clinical trial. The vaccine, galinpepimut-S (GPS), is an “off-the-shelf” vaccine invented by MSK leukemia specialist and physician-scientist Dr. David A. Scheinberg (@DASLab_MSKCC). In the trial of 126 patients, it reduced the risk of death by 41%. Median overall survival was 24.0 months with the vaccine compared with 14.7 months for patients on standard treatments. “These data bring us closer to having the first off-the-shelf vaccine for AML patients." Learn more: bit.ly/4fDoAmS
9
88
31
387
39,048
Umar Iqbal, MD retweeted
Kinda feel bad for Ed Boyden & Zhuo-Hua Pan Who's Zhuo-Hua Pan? See statnews.com/2016/09/01/opto…
BREAKING NEWS The 2026 #NobelPrize in Physiology or Medicine has been awarded to Karl Deisseroth, Peter Hegemann and Georg Nagel “for their discoveries concerning light-gated ion channels and optogenetics.”
7
4
39
11,482
The micro-environment at Houston was very hostile to dysplastic myeloid clones. #soho26
3
35
1,888
We're delighted to welcome our newest ⭐ class of hematology oncology fellows to @MoffittNews 🎉. Smiles all around as they kick off their journey with a comprehensive orientation month. We can't wait to see all they'll accomplish. Welcome to the Moffitt family!
5
1
18
2,500
Beautiful read.
🎉 BLR is thrilled to announce that “Two Thoracotomies” by Angela Tang-Tan has won a @PushcartPrize! Angela’s essay—from BLR Issue 49, our "Animalia" issue—parallels her experience in a research lab with a devastating overnight shift in the emergency room. blreview.org/news/recent-new…
337
Our gentle giant logging off from PD duties after a decade of shepherding @MoffittNews Onc fellowship. We crowned him as the “Greatest PD of all time!” (settled science, fact!) As Henry Adams said - “A teacher affects eternity.” True indeed.
1
2
272
Umar Iqbal, MD retweeted
Another creative idea in cancer therapy lately... A new @NatureMedicine * study transplanted CRISPR-edited donor stem cells with CD33 removed into patients with high-risk AML. Because the new marrow lacks CD33, a CD33-targeted drug (gemtuzumab) can then wipe out residual leukemia without harming the healthy donor cells.✅ All 30 patients engrafted (median 10 days). Relapse-free survival 14 months in a population where outcomes are usually much worse. Still early and intensive, but the idea is exciting: engineering normal tissue so cancer therapy can be more selective and safer.
4
11
1
67
4,813
Sobering, beautiful narrative medicine essay in JAMA: “Time is Finite”.
2
1
9
1,816
Umar Iqbal, MD retweeted
Spring in Kashmir 🌸
2
25
457
4,590
Check out this labor of love, a patient focused app for All things myeloma! By the very patient outcome focused Dr. Neupane!
🎉My New Year gift for the myeloma community: AllThingsMyeloma™ A free, patient-friendly app, born out of my passion for myeloma & integrating AI in oncology-to help individuals with MGUS/SMM/MM (& caregivers) better understand & manage their journey. ✅iOS & Android
1
2
919
Dal Lake Srinagar ❄️
5
15
3
252
5,661
Check our viewpoint published @JAMA_current #MedEd Abstract Factory—Research Culture Harming Medical Education The "abstract factory" is destroying medical education. Trainees and junior faculty compete with abstract counts instead of meaningful research. Result: inflated CVs, diluted conferences. We shouldn't celebrate this—you don't need publications to be a great doctor. ➡️jamanetwork.com/journals/jam… @utswcancer @rajshekharucms @HiraSMian @ManniMD1 @HemOncFellows @ASCOTECAG
30
171
25
625
172,305
At #ASH25: Umar Iqbal, MD (@umariqbalmed) presents early real-world data for revumenib confirming good tolerability with no adverse events leading to discontinuations. He shares that early efficacy data shows excellent activity across molecular and disease subsets. #MoffittASH25 @ASH_hematology
6
13
883
Spotted some of our hematology oncology fellows tonight at the #ASH25 poster session! #MoffittASH25
7
19
1,043
Umar Iqbal, MD retweeted
Huge congratulations to Amir Fathi for delivering one of the most impactful plenary presentations @ASH_hematology in AML in past decade. The PARADIGM study may lead to a Paradigm shift- Aza/Ven > intensive chemo in newly Dx high-risk AML. 👏👏👏
3
50
2
190
10,238
Umar Iqbal, MD (@umariqbalmed) shares early real-world data of the efficacy and tolerability of revumenib outside of a clinical trial setting. #MoffittASH25 @ASH_hematology
3
8
410
Umar Iqbal, MD retweeted
“When you are dying, at least in my limited experience, you start remembering everything.” Tatiana Schlossberg, the daughter of Caroline Kennedy, writes about receiving a terminal diagnosis. newyorkermag.visitlink.me/4S…
347
1,431
330
7,349
3,316,720
What comes after trials? Excited to share our early real world revumenib experience at ASH! Seems like AML armamentarium is broadening well.
2
1
8
1,187
Umar Iqbal, MD retweeted
Come join Nevada's first BMT/cell therapy! We are already super successful. We need another doc. I can only last so long doing Q2week call! We are helping patients in great need. I have never asked for a retweet, but colleagues please retweet. tinyurl.com/4zew3wab
7
58
4
121
18,360